Fauziya Naikar: Why the MTHFR Gene is a Critical Piece of the Fertility Puzzle
Fauziya Naikar, Junior Embryologist at Star IVF and Fertility Center, shared a post on LinkedIn:
“Why the MTHFR Gene is a Critical Piece of the Fertility Puzzle?
In the embryology lab, we spend our days perfecting morphokinetics and grading.
But beyond the petri dish, a ‘silent architect’ is at work: the MTHFR (Methylenetetrahydrofolate Reductase) gene.
Why do high-quality embryos sometimes fail to result in a live birth?
The answer often lies in the biochemical environment provided by parental genetics—specifically the methylation pathway.
The Molecular Breakdown.
The MTHFR enzyme is the critical rate-limiting step in the folate cycle.
Its primary job is to catalyze the conversion of folate into 5-methyltetrahydrofolate (5-MTHF).
This active form is the ‘fuel’ for two vital processes:
- DNA Methylation: This is the cornerstone of epigenetic programming during early cleavage stages. Without it, cellular repair and gene expression are compromised.
- Homocysteine Regulation: MTHFR converts homocysteine into methionine. When mutations like C677T or A1298C occur, enzyme efficiency can drop by 30 percent to 70 percent, causing homocysteine levels to spike.
The Embryologist’s Perspective: Why It Matters?
We see the effort it takes to create a viable embryo, but that embryo needs a stable environment to thrive post-transfer.
Elevated homocysteine (Hyperhomocysteinemia) is a known risk factor for micro-clots in the placental vasculature (Thrombophilia).
This can lead to:
- Implantation failure or early pregnancy loss.
- Neural tube defects (Spina Bifida, Anencephaly).
- Impaired blood flow to the uterus and placenta.
Clinical Pivot: From ‘Unexplained’ to ‘Targeted’.
The traditional reliance on synthetic Folic Acid may not be enough for patients with these genetic variants, as their bodies cannot efficiently convert it.
The Solution?
Bypassing the genetic ‘roadblock’ by using bioavailable Methylfolate (5-MTHF) along with Vitamins B6 and B12.
This targeted approach lowers homocysteine and optimizes the metabolic environment for the embryos we work so hard to cultivate.
By understanding these genomic markers, we move away from the frustration of ‘unexplained infertility’ and toward a more precise, personalized fertility protocol.

Stay updated with Hemostasis Today.
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria
-
Aug 10, 2026, 16:51Suebsarn Ruksakulpiwat։ A New Milestone in the Development of the Stroke Risk Screening Scales
-
Aug 10, 2026, 16:09Preetie Shetty Akkunje: Making Stroke Rehabilitation Accessible in Low-Resource Settings
-
Aug 10, 2026, 15:50The Next Antithrombotic Frontier: GPVI Inhibitors Beyond Aspirin